“Not surprising.” That was my response to the Health Care Fraud and Abuse Control Program Annual Report issued in February by the U.S. Department of Health and Human Services (HHS).
The Department of Health and Human Services announced on February 24 that it is seeking information about conducting a pre-audit survey.
Last week, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) and Office for the National Coordinator for Health Information Technology (ONC) issued model Notices of Privacy Practices (NPPs) in Spanish.
HHS has issued new guidance addressing when it is appropriate under the HIPAA Privacy Rule for a health care provider to share the protected health information of a patient who is being treated for a mental health condition.
The U.S. Department of Health and Human Services (HHS) recently published a Final Rule granting patients and their personal representatives access to the patient’s completed laboratory test reports directly from the lab maintaining the information.
Why is data breach such a rampant problem within the health care industry? As health care rapidly digitizes through adoption of electronic health records, mobile applications and the like, the risk of data breach is rising exponentially.
In a letter to Rep. Jim McDermott, Health and Human Services (HHS) Secretary Kathleen Sebelius answered a question frequently asked by healthcare providers and pharmaceutical and device manufacturers in the roll-up to implementation of the Affordable Care Act: “Are the qualified health plans (QHPs) established through the Act ‘federal health care programs’ under section 1128B of the Social Security Act?”
Just in time for the September 23, 2013, deadline for compliance with the HIPAA Omnibus Rule, the U.S. Department of Health and Human Services (“HHS”) issued a set of model notices of privacy practices for health care providers and group health plans, available at http://www.hhs.gov/ocr/privacy/hipaa/modelnotices.html.
On September 19, the Department of Health and Human Services issued new guidance on the “refill reminder” requirements under HIPAA that will have important implications for pharmaceutical manufacturer-funded communications to patients.
The Department of Health & Human Services (HHS) released on September 19, 2013 guidance on financially remunerated prescription refill reminders.